As a feasibility test, we first queried predicted DH for three genes FBL, LIN28A and BLMH in P493-6 B cell lymphoma (for which no public DNase-seq data are available) and H9 human embryonic stem cells. This evidence concerns the gene BLMH and B-cell non-Hodgkin lymphoma.